...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Exempt Distribution
5
Mar 15, 2020 12:34AM
3
Mar 16, 2020 07:05PM
3
Mar 16, 2020 08:06PM
3
Mar 16, 2020 08:08PM

I didn't Rvxoldtimer reported it as Us $

4
Mar 17, 2020 12:11PM
Share
New Message
Please login to post a reply